This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07279/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07279/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07279/identifier/drugbank/
n5http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07279/identifier/chemspider/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07279/identifier/pdb/

Statements

Subject Item
n2:DB07279
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n4:DB07279 n5:DB07279
dcterms:title
N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE
adms:identifier
n10:99443750 n11:896 n12:9820034 n13:7995783 n14:DB07279
n6:IUPAC-Name
n7:271B5BB9-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B5BBF-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B5BBE-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5BBB-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B5BBC-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B5BBD-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B5BB7-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B5BB8-363D-11E5-9242-09173F13E4C5 n7:271B5BB5-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B5BB6-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B5BC5-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B5BC6-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B5BC0-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B5BC1-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B5BC3-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B5BC2-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5BC4-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5BCA-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B5BCC-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B5BCD-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B5BC9-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B5BC8-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B5BCB-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B5BBA-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B5BC7-363D-11E5-9242-09173F13E4C5